FJ Capital Management LLC, Financial Opportunity Fund LLC, and Martin Friedman filed Amendment No. 3 to a Schedule 13G with the SEC on November 13, 2026, disclosing a combined beneficial ownership position in Southern First Bancshares, Inc. (NASDAQ:SFST) as of September 30, 2026.
Director John Earl Jackson filed a Form 4 with the SEC on November 13, 2026, disclosing open-market purchases of Natural Gas Services Group Inc common stock and a restricted stock unit award on the same date.
Steven J. McLaughlin, a director and 10% owner of Expensify, Inc. (NASDAQ:EXFY), filed an amended Form 4/A on November 13, 2026, correcting a previously reported transaction code for sales of Class A Common Stock that occurred November 9 through November 11, 2026.
Stephen S. Romaine, President and CEO of Tompkins Financial Corp, filed a Form 4 on November 13, 2026, reporting a disposition of 445 shares of common stock on November 12, 2026, to cover taxes upon the vesting of restricted stock.
Director James S. Abernethy filed a Form 4 with the SEC on November 13, 2026, disclosing a sale of 1,000 shares of Peoples Bancorp of North Carolina common stock on November 12, 2026.
The Cannaisseur Group, Inc. (OTC:TCRG), a Delaware-incorporated cannabis-sector holding company based in Atlanta, Georgia, filed its Form 10-Q for the quarterly period ended September 30, 2026, with the SEC on November 13, 2026.
Central Bancompany, Inc. filed a Form 10-Q quarterly report with the U.S. Securities and Exchange Commission on November 13, 2026, covering the fiscal quarter ended September 30, 2026.
Spark I Acquisition Corporation filed its Form 10-Q for the quarter ended September 30, 2026, with the SEC on November 13, 2026, reporting a net loss of $3,366,062 for the nine months ended September 30, 2026.
Franklin Solana ETF, a series of Franklin Solana Trust sponsored by Franklin Holdings, LLC, filed a Form 10-Q with the SEC on November 13, 2026, covering the quarterly period ended September 30, 2026, and listing its shares on NYSE Arca under the symbol SOEZ.
Mahesh V. Patel, Chief Executive Officer and Director of Lipocine Inc., filed a Form 4 on November 13, 2026, disclosing open-market purchases of common stock on November 12 and November 13, 2026.